Clinical Pharmacology and Drug Toxicity Practice Questions

Q: 1% w/v of methylene blue is injected intravenously to reverse the toxic effects of which condition?

Methaemoglobinemia. **Explanation:** **1. Mechanism of Action (Why A is correct):** Methylene blue is the treatment of choice for **acquired methaemoglobinemia**. In this condition, the ferrous iron ($Fe^{2+}$) in hemoglobin is oxidized to the ferric state ($Fe^{3+}$), which cannot bind oxygen. Methylene blue acts as an exogenous electron carrier. Once injected, it is converted by the enzyme **NADPH-methaemoglobin reductase** into **leukomethylene blue**. Leukomethylene blue then reduces the ferric iron ($Fe^{3+}$) back to the functional ferrous state ($Fe^{2+}$), restoring the oxygen-carrying capacity of the blood. **2. Analysis of Incorrect Options:** * **B. Oxygen toxicity:** Managed by reducing the fraction of inspired oxygen ($FiO_2$) and supportive care; methylene blue has no role here. * **C. Crohn’s disease:** This is an inflammatory bowel disease treated with aminosalicylates, corticosteroids, or biologics (e.g., Infliximab). * **D. Lidocaine toxicity:** Severe systemic toxicity (LAST) is treated with **Intravenous Lipid Emulsion (ILE) 20%**. While lidocaine can *cause* methaemoglobinemia as a side effect, methylene blue treats the resulting condition, not the lidocaine toxicity itself. **3. NEET-PG High-Yield Pearls:** * **Dosage:** 1–2 mg/kg (1% solution) IV over 5 minutes. * **Contraindication:** Methylene blue is contraindicated in patients with **G6PD deficiency**, as it can precipitate severe hemolysis (due to insufficient NADPH to reduce the drug). * **Clinical Sign:** Methaemoglobinemia presents with "chocolate-colored blood" and central cyanosis that does not improve with supplemental oxygen. * **Paradoxical effect:** At very high doses, methylene blue can itself induce methaemoglobinemia.

Q: Drugs can cause all of the following pulmonary manifestations except?

Atelectasis. **Explanation:** Drug-induced pulmonary disease is a high-yield topic in NEET-PG, as many systemic medications have specific respiratory toxicities. **1. Why Atelectasis is the correct answer:** Atelectasis refers to the collapse of lung tissue (alveoli). It is primarily a **mechanical or obstructive process** (e.g., mucus plugging, tumors, or post-surgical shallow breathing) rather than a direct toxicological effect of drugs on the lung parenchyma. While drugs like opioids can cause hypoventilation which *leads* to atelectasis, it is not considered a direct "drug-induced pulmonary manifestation" in clinical pharmacology. **2. Why the other options are incorrect (Drug-induced causes):** * **Pulmonary Eosinophilia (Löffler’s Syndrome):** Classically caused by **Nitrofurantoin**, Sulfonamides, and NSAIDs. It presents with peripheral eosinophilia and fleeting pulmonary infiltrates. * **Asthma (Bronchospasm):** Frequently triggered by **NSAIDs** (via leukotriene shift), **Beta-blockers** (due to B2 blockade), and Cholinergic drugs. * **ARDS (Non-cardiogenic Pulmonary Edema):** Can be caused by an overdose of **Salicylates (Aspirin)**, Opioids, or certain chemotherapeutic agents like Cytarabine and Gemcitabine. **High-Yield Clinical Pearls for NEET-PG:** * **Pulmonary Fibrosis:** The most common drug-induced interstitial lung disease. Key culprits: **Amiodarone**, **Bleomycin**, **Busulfan**, and Methotrexate. * **Systemic Lupus Erythematosus (SLE) with Pleuritis:** Caused by **Hydralazine, Procainamide, and Isoniazid** (HIP). * **Amiodarone:** Unique because it causes "foamy macrophages" in the alveoli due to phospholipidosis. * **Bleomycin:** Toxicity is dose-dependent and exacerbated by high concentrations of inspired oxygen ($FiO_2$).

Q: Which of the following drugs cause methemoglobinemia?

All of the above. **Explanation:** **Methemoglobinemia** occurs when the iron in hemoglobin is oxidized from the **ferrous state (Fe²⁺)** to the **ferric state (Fe³⁺)**. Ferric iron cannot bind oxygen, and it also increases the oxygen affinity of the remaining ferrous hemes (shifting the oxygen-dissociation curve to the **left**), leading to tissue hypoxia and characteristic "chocolate-colored blood." **Analysis of Options:** * **Aniline (Option A):** Aniline dyes and industrial chemicals are classic oxidizing agents known to induce methemoglobinemia, often seen in occupational exposures. * **Dapsone (Option B):** This is the most common pharmacological cause. It undergoes hepatic metabolism to form hydroxylamine metabolites, which are potent oxidants. This is a critical side effect to monitor in patients treated for Leprosy or *Pneumocystis jirovecii*. * **Nitrates/Nitrites (Option C):** Nitrates (found in well water or medications like Nitroglycerin and Amyl nitrite) are potent triggers. In infants ("Blue Baby Syndrome"), intestinal bacteria convert nitrates to nitrites, which easily oxidize fetal hemoglobin. Since all three substances are well-documented oxidizing agents that convert Fe²⁺ to Fe³⁺, **Option D (All of the above)** is the correct answer. **High-Yield Clinical Pearls for NEET-PG:** * **Clinical Sign:** Central cyanosis that does not improve with supplemental oxygen, with normal $PaO_2$ on ABG but low $SaO_2$ (Oxygen saturation gap). * **Drug of Choice:** **Methylene Blue** (acts as a cofactor for NADPH-methemoglobin reductase to reduce Fe³⁺ back to Fe²⁺). * **Contraindication:** Avoid Methylene Blue in patients with **G6PD deficiency**, as it can precipitate hemolysis; use Vitamin C (Ascorbic acid) instead. * **Other common causes:** Benzocaine (local anesthetic), Primaquine, and Sulfonamides.

Q: Overexposure to D-penicillamine results in which of the following?

Sideroblastic anemia. **Explanation:** **D-penicillamine** is a chelating agent used in the treatment of Wilson’s disease, cystinuria, and rheumatoid arthritis. **Why Sideroblastic Anemia is Correct:** D-penicillamine acts as a **Pyridoxine (Vitamin B6) antagonist**. It reacts with pyridoxal phosphate to form a thiazolidine derivative, rendering the vitamin inactive. Pyridoxine is a crucial cofactor for the enzyme **ALAS (delta-aminolevulinate synthase)**, which is the rate-limiting step in heme synthesis. A deficiency or inhibition of this pathway prevents iron from being incorporated into protoporphyrin, leading to iron accumulation in the mitochondria of developing RBCs, visible as "ringed sideroblasts." Thus, overexposure results in **Sideroblastic Anemia**. **Analysis of Incorrect Options:** * **Option A:** D-penicillamine is the treatment of choice for Wilson’s disease; it **removes** copper from the body. It does not cause copper toxicity. * **Option C:** D-penicillamine can actually cause hematological cytopenias (thrombocytopenia) and nephrotic syndrome, but it is not typically associated with a hypercoagulable state. * **Option D:** There is no established clinical link between D-penicillamine and dyslipidemia. **High-Yield Clinical Pearls for NEET-PG:** * **Antidote:** Sideroblastic anemia caused by D-penicillamine or Isoniazid (INH) can be reversed by administering **Pyridoxine (B6)**. * **Other Side Effects:** D-penicillamine is notorious for causing **autoimmune-like syndromes**, including Drug-induced Lupus, Myasthenia Gravis, and Goodpasture’s syndrome. * **Dermatology Link:** It can cause **Elastosis Perforans Serpiginosa (EPS)** due to its effect on collagen cross-linking.

Q: Which of the following is NOT a sign of Organophosphorus poisoning?

Bronchodilatation. **Explanation:** Organophosphorus (OP) compounds act by irreversibly inhibiting the enzyme **Acetylcholinesterase (AChE)**. This leads to an accumulation of Acetylcholine (ACh) at both muscarinic and nicotinic receptors, resulting in a "cholinergic crisis." **Why Bronchodilatation is the correct answer:** In OP poisoning, excess ACh stimulates **M3 receptors** in the bronchial smooth muscle, leading to **bronchoconstriction** and increased bronchial secretions (bronchorrhea). Bronchodilatation is a sympathetic (adrenergic) response, not a cholinergic one. Therefore, it is NOT a sign of OP poisoning. **Analysis of Incorrect Options:** * **Bradycardia:** Excess ACh stimulates **M2 receptors** in the heart (specifically the SA node), leading to a decrease in heart rate. * **Salivation:** Stimulation of **M3 receptors** in the exocrine glands causes profuse sweating, lacrimation, and salivation (part of the SLUDGE mnemonic). * **Miosis:** ACh acts on the **M3 receptors** of the sphincter pupillae muscle, causing pupillary constriction (pin-point pupils). **NEET-PG High-Yield Pearls:** * **Mnemonics:** Remember **DUMBELS** (Diarrhea, Urination, Miosis, Bradycardia/Bronchospasm, Emesis, Lacrimation, Salivation) or **SLUDGE**. * **Nicotinic Effects:** While muscarinic effects are common, OP poisoning also causes nicotinic effects like muscle fasciculations and weakness. * **Management:** The specific antidote is **Atropine** (reverses muscarinic effects; dose titrated until "atropinization" i.e., clearing of secretions). **Pralidoxime (2-PAM)** is used as a cholinesterase regenerator if given before "aging" of the enzyme occurs. * **Cause of Death:** Usually respiratory failure due to bronchoconstriction, excessive secretions, and paralysis of respiratory muscles.

Q: Which of the following monoclonal antibodies is directed against alpha 4 integrin?

Natalizumab. **Explanation:** **Natalizumab** is a humanized monoclonal antibody that targets the **$\alpha$4-subunit of integrins** ($\alpha$4$\beta$1 and $\alpha$4$\beta$4) [1], [2]. These integrins are expressed on the surface of all leukocytes except neutrophils [1]. By binding to $\alpha$4-integrin, Natalizumab prevents leukocytes from adhering to the Vascular Cell Adhesion Molecule-1 (VCAM-1) on the blood-brain barrier and intestinal lining [2]. This inhibits the migration of inflammatory cells into the CNS and gut, making it highly effective for **Multiple Sclerosis** and **Crohn’s disease** [1], [2]. **Analysis of Incorrect Options:** * **Efalizumab:** Targets **CD11a**, a subunit of Leukocyte Function-associated Antigen-1 (LFA-1). It was used for psoriasis but was withdrawn due to the risk of Progressive Multifocal Leukoencephalopathy (PML). * **Ibalizumab:** A "post-attachment inhibitor" that binds to the **CD4 receptor**, preventing HIV-1 from entering host cells. * **Tocilizumab:** An **Interleukin-6 (IL-6) receptor antagonist** used in Rheumatoid Arthritis, Giant Cell Arteritis, and Cytokine Release Syndrome (CRS). **High-Yield Clinical Pearls for NEET-PG:** * **PML Risk:** The most significant adverse effect of Natalizumab is **Progressive Multifocal Leukoencephalopathy (PML)**, caused by the reactivation of the **JC virus** [2]. Patients must be screened for anti-JCV antibodies before starting therapy. * **Integrin Targets:** * $\alpha$4$\beta$7 integrin (gut-specific): **Vedolizumab** (used in Ulcerative Colitis). * $\alpha$IIb$\beta$3 integrin (platelets): **Abciximab** (antiplatelet agent). * **Mnemonic:** "Nata-**4**-zumab" for **$\alpha$4**-integrin.

Q: Which of the following statements about cyclosporine is false?

It is given only orally.. ### Explanation **1. Why Option A is the Correct Answer (False Statement):** Cyclosporine is **not** given only orally. It has a variable and incomplete absorption from the gastrointestinal tract (bioavailability ~30%). Therefore, it is available in both **oral** (capsules/solution) and **intravenous (IV)** formulations. The IV route is typically reserved for patients who cannot tolerate oral medication or those in the immediate post-transplant period. Additionally, it is used topically as ophthalmic drops for dry eyes (Sjögren’s syndrome). **2. Analysis of Incorrect Options (True Statements):** * **Option B:** Cyclosporine is a cornerstone in **solid organ transplantation**, including renal, hepatic, and cardiac transplants, to prevent graft rejection. * **Option C:** It is a **calcineurin inhibitor**. It binds to cyclophilin, forming a complex that inhibits calcineurin. This prevents the dephosphorylation of NFAT (Nuclear Factor of Activated T-cells), leading to decreased IL-2 production and selective inhibition of T-lymphocyte proliferation. * **Option D:** **Nephrotoxicity** is the most common and serious adverse effect of cyclosporine. It causes dose-related constriction of afferent arterioles, leading to decreased GFR. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Calcineurin Inhibitor → ↓IL-2 → ↓T-cell activation. * **Adverse Effect Mnemonic (6 H's):** **H**ypertension, **H**yperplasia of gums (gingival hyperplasia), **H**irsutism, **H**yperlipidemia, **H**yperkalemia, and **H**epatotoxicity (along with Nephrotoxicity). * **Monitoring:** It requires **Therapeutic Drug Monitoring (TDM)** due to its narrow therapeutic index and cytochrome P450 (CYP3A4) mediated metabolism. * **Comparison:** Unlike Tacrolimus (another calcineurin inhibitor), Cyclosporine is more likely to cause hirsutism and gum hyperplasia, whereas Tacrolimus is more associated with hyperglycemia/diabetes.

Q: Which of the following drugs is deposited in the retina?

Chloroquine. **Explanation:** **Chloroquine (Option B)** is the correct answer because it has a high affinity for melanin-containing tissues. The drug binds to melanin in the **retinal pigment epithelium (RPE)**, leading to its accumulation and subsequent damage to the photoreceptors. This toxicity manifests clinically as **"Bull’s Eye Maculopathy"** (a central area of depigmentation surrounded by a ring of hyperpigmentation). Because chloroquine has a very large volume of distribution and a long half-life, it remains deposited in the retina long after the drug is discontinued, necessitating regular ophthalmological screening (Amsler grid test, Fundus examination). **Why the other options are incorrect:** * **Isoniazid (Option A):** Primarily associated with **Optic Neuritis** (inflammation of the optic nerve) rather than retinal deposition. It also causes peripheral neuropathy due to Vitamin B6 (pyridoxine) deficiency. * **Rifampicin (Option C):** Known for causing harmless **orange-red discoloration** of body secretions (tears, sweat, urine) but does not deposit in or damage the retinal tissue. * **Pyrazinamide (Option D):** Its most significant side effects are hepatotoxicity and hyperuricemia (leading to gout); it has no significant ocular toxicity. **High-Yield Clinical Pearls for NEET-PG:** 1. **Bull’s Eye Maculopathy:** Classic buzzword for Chloroquine/Hydroxychloroquine toxicity. 2. **Vigabatrin:** Another high-yield drug causing "permanent concentric visual field loss." 3. **Ethambutol:** Most common anti-tubercular drug causing **Retrobulbar Neuritis** (red-green color blindness). 4. **Thioridazine:** An antipsychotic also known for causing pigmentary retinopathy.

Q: A patient presents with bleeding due to warfarin overdose. As a treating physician, what is the immediate treatment for warfarin-induced bleeding?

Fresh frozen plasma. **Explanation:** The management of warfarin toxicity depends on the severity of bleeding and the INR levels. Warfarin acts by inhibiting **Vitamin K Epoxide Reductase (VKOR)**, leading to a deficiency of active clotting factors **II, VII, IX, and X**. **Why Fresh Frozen Plasma (FFP) is correct:** In the event of **active bleeding** due to warfarin, the priority is the immediate replacement of functional clotting factors. FFP contains all coagulation factors and provides a rapid reversal of the anticoagulant effect. While **Prothrombin Complex Concentrate (PCC)** is technically the first-line treatment for life-threatening bleeds (as it works faster and avoids fluid overload), **FFP** is the standard correct choice among the provided options for immediate reversal in a clinical setting. **Analysis of Incorrect Options:** * **Vitamin K Injection (Option D):** While Vitamin K is the specific antidote for warfarin, it acts by promoting the hepatic synthesis of *new* clotting factors. This process takes **6–24 hours** to show effect, making it unsuitable for "immediate" control of active bleeding. * **Cryoprecipitate (Option A):** This is rich in Fibrinogen, Factor VIII, Factor XIII, and vWF. It is primarily used for hemophilia A, von Willebrand disease, or hypofibrinogenemia, not for warfarin reversal. * **Platelet Concentrate (Option B):** Warfarin affects soluble clotting factors, not platelet count or function. Platelet transfusion is indicated in thrombocytopenia or antiplatelet drug toxicity. **High-Yield NEET-PG Pearls:** * **Antidote for Warfarin:** Vitamin K (Phytonadione). * **Immediate Reversal:** PCC (Best) > FFP (Next best). * **Monitoring:** Warfarin is monitored by **PT/INR** (Extrinsic pathway). * **Teratogenicity:** Warfarin causes **Fetal Warfarin Syndrome** (stippled epiphyses, nasal hypoplasia); it is contraindicated in pregnancy (except for mechanical heart valves in specific trimesters).

Question 1

1% w/v of methylene blue is injected intravenously to reverse the toxic effects of which condition?

Accepted Answer

Methaemoglobinemia

Answer

Oxygen toxicity

Answer

Crohn's disease

Answer

Lidocaine toxicity

Question 2

Drugs can cause all of the following pulmonary manifestations except?

Accepted Answer

Atelectasis

Answer

Pulmonary eosinophilia

Answer

Asthma

Answer

ARDS

Question 3

In which of the following conditions is intravenous immunoglobulin therapy indicated?

Accepted Answer

Idiopathic thrombocytopenic purpura

Answer

Myasthenia gravis

Answer

Hemolytic-uremic syndrome

Answer

Multiple myeloma

Question 4

Which of the following drugs cause methemoglobinemia?

Accepted Answer

All of the above

Answer

Aniline

Answer

Dapsone

Answer

Nitrates

Question 5

Overexposure to D-penicillamine results in which of the following?

Accepted Answer

Sideroblastic anemia

Answer

Copper toxicity in the retina

Answer

Hypercoagulable state

Answer

Dyslipidemia

Question 6

Which of the following is NOT a sign of Organophosphorus poisoning?

Accepted Answer

Bronchodilatation

Answer

Bradycardia

Answer

Salivation

Answer

Miosis

Question 7

Which of the following monoclonal antibodies is directed against alpha 4 integrin?

Accepted Answer

Natalizumab

Answer

Efalizumab

Answer

Ibalizumab

Answer

Tocilizumab

Question 8

Which of the following statements about cyclosporine is false?

Accepted Answer

It is given only orally.

Answer

It is given in renal transplant.

Answer

It selectively inhibits T-lymphocyte proliferation.

Answer

It causes renal toxicity.

Question 9

Which of the following drugs is deposited in the retina?

Accepted Answer

Chloroquine

Answer

Isoniazid

Answer

Rifampicin

Answer

Pyrazinamide

Question 10

A patient presents with bleeding due to warfarin overdose. As a treating physician, what is the immediate treatment for warfarin-induced bleeding?

Accepted Answer

Fresh frozen plasma

Answer

Cryoprecipitate

Answer

Platelet concentrate

Answer

Vitamin K injection

Clinical Pharmacology and Drug Toxicity — MCQs

Clinical Pharmacology and Drug Toxicity — MCQs

On this page

Practice by Chapter

Want unlimited practice?